Skip to Content

Eaton Vance Worldwide Health Sci A ETHSX

Analyst rating as of
NAV / 1-Day Return
13.14  /  1.13 %
Total Assets
1.2 Bil
Adj. Expense Ratio
1.160%
Expense Ratio
1.160%
Fee Level
Below Average
Longest Manager Tenure
5.56 years
Category
Health
Investment Style
Large Blend
Min. Initial Investment
1,000
Status
Open
TTM Yield
0.22%
Turnover
32%
Premium

Morningstar’s Analysis

Will ETHSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Not a standout in its category.

Senior Analyst

Summary

| |

Eaton Vance Worldwide Health Sciences does not have any pronounced advantages over its competition at this point in time, and all its share classes earn Morningstar Analyst Ratings of Neutral.

Unlock our full analysis with Morningstar Premium